Inspire Medical Systems Inc(INSP) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 14.79 | EPS (ttm) | 4.6 | Insider Own | 5.74% | Shs Outstand | 28.9M | Perf Week | 8.01% |
| Market Cap | 1.97B | Forward P/E | 46.34 | EPS next Y | 23.15% | Insider Trans | -0.3% | Shs Float | 27.3M | Perf Month | 15.2% |
| Enterprise Value | 1.68B | PEG | - | EPS next Q | 0.08 | Inst Own | 124.02% | Short Float | 16.05% | Perf Quarter | 61.12% |
| Income | 0.14B | P/S | 2.19 | EPS this Y | -50.67% | Inst Trans | -4.57% | Short Ratio | 5.18 | Perf Half Y | 13.59% |
| Sales | 0.90B | P/B | 2.39 | EPS next 5Y | -7.02% | ROA | 15.63% | Short Interest | 4.37M | Perf YTD | -26.14% |
| Book/sh | 28.56 | P/C | 6.14 | EPS past 3/5Y | - | ROE | 17.96% | 52W High | -53.67% ($147.03) | Perf Year | -13.52% |
| Cash/sh | 11.09 | P/FCF | 16.82 | Sales past 3/5Y | 30.77% 51.21% | ROIC | 15.8% | 52W Low | 75.07% ($38.91) | Perf 3Y | -69.66% |
| Dividend Est. | - | EV/EBITDA | 23.52 | EPS Y/Y TTM | 161.83% | Gross Margin | 86.13% | Volatility(W/M) | 5.51% 4.17% | Perf 5Y | -71.27% |
| Dividend TTM | - | EV/Sales | 1.87 | Sales Y/Y TTM | 4.35% | Oper. Margin | 6.02% | ATR (14) | 2.93 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.16 | EPS Q/Q | 108.87% | Profit Margin | 15.03% | RSI (14) | 70.08 | Recom | 2.78 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.55 | Sales Q/Q | -7.6% | SMA20 | 10.64% ($61.57) | Beta | 0.74 | Target Price | $60.4 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2026/8/3 | SMA50 | 21.12% ($56.24) | Rel Volume | 1.35 | Prev Close | $66.48 |
| Employees | 1333 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | 159.35% 3.01% | SMA200 | 3.34% ($65.92) | Avg Volume(3M) | 0.84M | Price | $68.12 |
| IPO | 2018/5/3 | Option/Short | Yes/Yes | Trades | 16589 | Volume | 1,136,003 | Change | 2.47% |
Company
INSP is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
😴 Inspire Medical Systems (INSP) is a U.S. medical device company that develops and sells minimally invasive neurostimulation therapy systems for patients with obstructive sleep apnea. Its implantable "Inspire therapy" stimulates the hypoglossal nerve to keep the airway open and has established itself as an alternative for moderate-to-severe patients who cannot tolerate conventional CPAP machines, building a distinct treatment category within the sleep apnea market.
Over the past 1 year, roughly in the middle
54% below its 1-year high.
INSP makes money exceptionally well
Strong earnings and excellent financial health
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -50.7% this year.
Tap to view numbers
The price looks about right
Trading at 14.8 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -69.7% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 124.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
XHE 0.02%
RNIN 0.01%
HEAL 0.01%
FSGS 0.01%
SFLO 0.01%It ranks #4 in the industry
Based on market cap of $2B.
INSP $2B PER 14.8
ABT $179B PER 33.4
MDT $117B PER 22.6
SYK $104B PER 28.0
FAQ
What kind of company is INSP?
INSP belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of INSP?
The market cap of INSP is approximately $2.0B, ranking 2,118 within its sector.
What is the P/E ratio of INSP?
INSP has a P/E ratio of approximately 14.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for INSP?
INSP has recorded a 52-week high of $147.03 and a low of $38.91.
